QuiVad

Home / Funds / Keel Capital S.A., Sicav-Sif – Foghorn X2

Keel Capital S.A., Sicav-Sif – Foghorn X2

Every short position this fund has disclosed, market by market.

Follow

This fund discloses no open short position today.

Follow by RSS

Get the moves on Keel Capital S.A., Sicav-Sif – Foghorn X2 by mail.

There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.

History of disclosures

155 disclosures on record for this fund.
DateIssuerMarket% of capitalEnd of publication
July 4, 2019Cellavision ABSweden0.51%
July 3, 2019Byggmax Group ABSweden1.11%
July 3, 2019Recipharm AB (publ)Sweden0.82%
July 3, 2019Skistar AktiebolagSweden0.70%
June 26, 2019Bilia ABSweden0.80%
June 25, 2019Bilia ABSweden0.80%
June 19, 2019Skistar AktiebolagSweden0.60%
June 18, 2019Skistar AktiebolagSweden0.60%
June 13, 2019Raysearch Laboratories AB (Publ)Sweden0.71%
June 12, 2019Raysearch Laboratories AB (publ)Sweden0.71%
May 31, 2019Raysearch Laboratories AB (Publ)Sweden0.62%
May 30, 2019Raysearch Laboratories AB (publ)Sweden0.62%
May 27, 2019Raketech Group Holding PLCSweden0.00%
May 23, 2019Byggmax Group ABSweden1.00%
May 22, 2019Byggmax Group ABSweden1.00%
May 22, 2019Raysearch Laboratories AB (Publ)Sweden0.50%
May 21, 2019Raysearch Laboratories AB (publ)Sweden0.50%
May 14, 2019Raketech Group Holding PLCSweden0.60%
May 13, 2019Raketech Group Holding PLCSweden0.60%
May 8, 2019Recipharm AB (Publ)Sweden0.70%
May 7, 2019Recipharm AB (publ)Sweden0.70%
May 3, 2019Recipharm AB (Publ)Sweden0.67%
May 2, 2019Recipharm AB (publ)Sweden0.67%
April 18, 2019Byggmax Group ABSweden0.95%
April 17, 2019Byggmax Group ABSweden0.95%
February 8, 2019Raysearch Laboratories AB (publ)Sweden0.00%
February 4, 2019Bilia ABSweden0.71%
February 3, 2019Bilia ABSweden0.71%
January 25, 2019Recipharm AB (Publ)Sweden0.50%
January 24, 2019Recipharm AB (publ)Sweden0.50%
January 11, 2019Byggmax Group ABSweden0.82%
January 10, 2019Byggmax Group ABSweden0.82%
January 3, 2019Raysearch Laboratories AB (Publ)Sweden0.56%
January 3, 2019Skistar AktiebolagSweden0.51%
January 2, 2019Byggmax Group ABSweden0.75%
January 2, 2019Raysearch Laboratories AB (publ)Sweden0.56%
January 2, 2019Skistar AktiebolagSweden0.00%
January 1, 2019Byggmax Group ABSweden0.75%
December 27, 2018Skistar AktiebolagSweden0.51%
December 26, 2018Skistar AktiebolagSweden0.51%
December 21, 2018Bilia ABSweden0.64%
December 20, 2018Bilia ABSweden0.64%
December 14, 2018Raysearch Laboratories AB (Publ)Sweden0.67%
December 13, 2018Raysearch Laboratories AB (publ)Sweden0.67%
December 3, 2018Byggmax Group ABSweden0.80%
December 2, 2018Byggmax Group ABSweden0.80%
November 20, 2018Raysearch Laboratories AB (Publ)Sweden0.71%
November 20, 2018Bilia ABSweden0.52%
November 19, 2018Raysearch Laboratories AB (publ)Sweden0.71%
November 19, 2018Bilia ABSweden0.52%

Download 155 filings as CSV Columns: Date, Issuer, Market, Disclosed position, Unit, End date. The other formats

Cite this page

The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.

QuiVad, Keel Capital S.A., Sicav-Sif – Foghorn X2, data as at September 27, 2019, https://www.quivad.com/detenteur/keel-capital-s-a-sicav-sif-foghorn-x2?page=2